Dipyrone and blood dyscrasia revisited: "Non-evidence based medicine"

Sao Paulo Medical Journal

Volumn 123, Issue 3, 2005, Pages 99-100

  Benseñor, Isabela M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTITHYROID AGENT; CIMETIDINE; CLOMIPRAMINE; COTRIMOXAZOLE; DIPYRONE; INDOMETACIN; NON PRESCRIPTION DRUG; PARACETAMOL; PENICILLAMINE; PENICILLIN G; PHENYLBUTAZONE; SALAZOSULFAPYRIDINE;

AGRANULOCYTOSIS; APLASTIC ANEMIA; BLOOD DYSCRASIA; BRAZIL; DRUG MEGADOSE; EDITORIAL; HUMAN; INCIDENCE; LIVER NECROSIS; MEDLINE; MEXICO; MIGRAINE; PAIN; PRESCRIPTION; SOUTH AND CENTRAL AMERICA; SUICIDE; THAILAND;

EID: 22244431564     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802005000300001     Document Type: Editorial

References (14)

1. Hamerschlak N, Maluf E, Paquini R, et al. LATIN study - Incidence of aplastic anemia and agranulocytosis in Latin America. Sao Paulo Med J. 2005;123(3):101-4.
2. Shapiro S, Issaragrisil S, Kaufman DW, et al. Agranulocytosis in Bangkok, Thailand: a predominantly drug-induced disease with an unusually low incidence. Aplastic Anemia Study Group. Am J Trop Med Hyg. 1999;60(4):573-7.
3. van der Klauw MM, Goudsmit R, Halie MR, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159(4):369-74.
4. Risks of agranulocytosis and aplastic anemia. A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study. JAMA. 1986;256(13):1749-57.
5. Dorr VJ, Cook J. Agranulocytosis and near fatal sepsis due to "Mexican aspirin" (dipyrone). South Med J. 1996;89(6):612-4.
6. Hargis JB, La Russa VF, Redmond J, Kessler SW, Wright DG. Agranulocytosis associated with "Mexican aspirin" (dipyrone): evidence for an autoimmune mechanism affecting multipotential hematopoietic progenitors. Am J Hematol. 1989;31(3):213-5.
7. Benseñor IM. To use or not to use dipyrone? Or maybe, Central Station versus ER? That is the question. Sao Paulo Med J. 2001;119(6):190-1.
8. Edwards JE, McQuay HJ. Dipyrone and agranulocytosis: what is the risk? Lancet. 2002;360(9344):1438.
9. Hawton K. United Kingdom legislation on pack sizes of analgesics: background, rationale, and effects on suicide and deliberate self-harm. Suicide Life Threat Behav. 2002;32(3):223-9.
10. Townsend E, Hawton K, Harriss L, Bale E, Bond A. Substances used in deliberate self-poisoning 1985-1997: trends and associations with age, gender, repetition and suicide intent. Soc Psychiatry Psychiatr Epidemiol. 2001;36(5):228-34.
11. Cranney M, Cranney J, Stubbs H. Limitation of over the counter sales of paracetamol. Packaging policy is unlikely to achieve its aim of reducing suicide. BMJ. 1998;317(7173):1657.
12. Neeleman J, Wessely S. Drugs taken in fatal and non-fatal self-poisoning: a study in south London. Acta Psychiatr Scand. 1997;95(4):283-7.
13. Skarupski KA, Mrvos R, Krenzelok EP. A profile of calls to a poison information center regarding older adults. J Aging Health. 2004;16(2):228-47.
14. Lo A, Shalansky S, Leung M, Hollander Y, Raboud J. Patient characteristics associated with nonprescription drug use in intentional overdose. Can J Psychiatry. 2003;48(4):232-6.